WEZLANA
NDC 84612-066, ustekinumab-auub, injection, solution, from Nuvaila Limited.
- Product NDC
- 84612-066
- Status
- Listed
- Labeler
- Nuvaila Limited
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761331
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/84612-066 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- USTEKINUMAB130 mg/26mL
Pharmacologic classes
Interleukin-12 Antagonist [EPC]; Interleukin-12 Antagonists [MoA]; Interleukin-23 Antagonist [EPC]; Interleukin-23 Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 84612-066-01 | 84612006601 | 1 VIAL in 1 CARTON (84612-066-01) / 26 mL in 1 VIAL |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/a6c23978-09f0-4796-88f7-d0ce7e3ed04eMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=84612-066
Use it
Look up 84612-066 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/84612-066 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 84612-066. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.